Section of Colon and Rectal Surgery, Department of Surgery, Hospital del Mar, Passeig Marítim 25-29, 08003, Barcelona, Spain.
Colorectal Cancer Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Clin Transl Oncol. 2018 Oct;20(10):1321-1328. doi: 10.1007/s12094-018-1866-8. Epub 2018 Apr 5.
Recurrence occurs in up to 20% of patients with stage II colon cancer operated on for cure. Although postoperative intra-abdominal infection has been linked with an increased risk of recurrence, the association is controversial. The aim was to investigate the impact of postoperative intra-abdominal infection on disease-free survival and disease-specific survival in patients with stage II colon cancer.
Patients undergoing elective surgery for colon cancer stage II, between 2003 and 2014, were included. Patients with anastomotic leak or intra-abdominal abscess were included in the infection group. We used the Kaplan-Meier method to represent the distribution of survival and the Cox proportional hazards model to estimate the contribution of relevant clinicopathological factors with prognosis.
Postoperative intra-abdominal infection was diagnosed in 37 of 363 (10.2%) patients. Perioperative blood transfusion was more frequent in patients with infection (p = 0.008). Overall 5-year disease-free survival rate was 85.1%. Disease-free survival at 5 years was lower in patients with postoperative intra-abdominal infection (52.8 vs 88.7%; p < 0.001), perineural invasion (p = 0.001), lymphovascular invasion (p = 0.001), pT4 (p = 0.013), and in patients with adjuvant chemotherapy (p = 0.013). Multivariate analysis showed that postoperative intra-abdominal infection (HR 4.275; p < 0.001), perineural invasion (HR 2.230; p = 0.007), and lymphovascular invasion (HR 2.052; p = 0.016) were all significant independent predictors of reduced disease-free survival. Regarding specific survival, independent significant prognostic factors were the number of lymph nodes, lymphovascular invasion, and postoperative intra-abdominal infection.
In this series of patients with stage II colon cancer, postoperative intra-abdominal infection has an independent negative impact on disease-free survival and disease-specific survival.
接受手术治疗的 II 期结肠癌患者中,多达 20%的患者会出现复发。尽管术后腹腔内感染与复发风险增加有关,但这种关联存在争议。本研究旨在探讨 II 期结肠癌患者术后腹腔内感染对无病生存率和疾病特异性生存率的影响。
纳入 2003 年至 2014 年间接受 II 期结肠癌择期手术的患者。将吻合口漏或腹腔脓肿患者纳入感染组。我们使用 Kaplan-Meier 方法表示生存分布,并使用 Cox 比例风险模型估计与预后相关的临床病理因素的贡献。
363 例患者中,术后发生腹腔内感染 37 例(10.2%)。感染患者围手术期输血更为频繁(p=0.008)。总体 5 年无病生存率为 85.1%。感染患者 5 年无病生存率较低(52.8% vs 88.7%;p<0.001),存在神经周围侵犯(p=0.001)、脉管侵犯(p=0.001)、pT4(p=0.013)和接受辅助化疗的患者(p=0.013)。多因素分析显示,术后腹腔内感染(HR 4.275;p<0.001)、神经周围侵犯(HR 2.230;p=0.007)和脉管侵犯(HR 2.052;p=0.016)均为无病生存率降低的独立显著预测因素。至于特异性生存,独立的显著预后因素是淋巴结数量、脉管侵犯和术后腹腔内感染。
在本系列 II 期结肠癌患者中,术后腹腔内感染对无病生存率和疾病特异性生存率有独立的负面影响。